A detailed history of First Horizon Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 12 shares of JAZZ stock, worth $1,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$1,441
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$122.0 - $145.31 $3,538 - $4,213
-29 Reduced 70.73%
12 $1,000
Q2 2023

Aug 03, 2023

SELL
$122.5 - $147.16 $1,347 - $1,618
-11 Reduced 21.15%
41 $5,000
Q2 2022

Aug 02, 2022

SELL
$141.59 - $168.66 $1,982 - $2,361
-14 Reduced 21.21%
52 $8,000
Q1 2022

May 10, 2022

SELL
$129.64 - $160.7 $10,500 - $13,016
-81 Reduced 55.1%
66 $10,000
Q4 2021

Feb 09, 2022

SELL
$119.87 - $145.67 $2,037 - $2,476
-17 Reduced 10.37%
147 $18,000
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $11,706 - $16,815
91 Added 124.66%
164 $21,000
Q3 2021

Nov 09, 2021

SELL
$128.64 - $184.79 $8,876 - $12,750
-69 Reduced 48.59%
73 $9,000
Q1 2021

May 11, 2021

BUY
$150.19 - $173.5 $20,425 - $23,596
136 Added 2266.67%
142 $23,000
Q4 2020

Feb 11, 2021

SELL
$140.71 - $165.05 $5,346 - $6,271
-38 Reduced 86.36%
6 $0
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $9,807 - $13,404
-93 Reduced 67.88%
44 $6,000
Q3 2019

Oct 23, 2019

BUY
$125.18 - $143.24 $625 - $716
5 Added 3.79%
137 $17,000
Q2 2019

Aug 05, 2019

BUY
$125.55 - $144.48 $15,568 - $17,915
124 Added 1550.0%
132 $0
Q1 2019

Apr 26, 2019

SELL
$121.81 - $142.95 $22,291 - $26,159
-183 Reduced 95.81%
8 $0
Q2 2018

Aug 07, 2018

BUY
$146.33 - $183.18 $27,949 - $34,987
191 New
191 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.53B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.